New parameterization approaches of the LIE method to improve free energy calculations of PlmII-Inhibitors complexes

2010 Wiley Periodicals, Inc.

Détails bibliographiques
Publié dans:Journal of computational chemistry. - 1984. - 31(2010), 15 vom: 30. Nov., Seite 2723-34
Auteur principal: Valiente, Pedro A (Auteur)
Autres auteurs: Gil, Alejandro, Batista, Paulo R, Caffarena, Ernesto R, Pons, Tirso, Pascutti, Pedro G
Format: Article en ligne
Langue:English
Publié: 2010
Accès à la collection:Journal of computational chemistry
Sujets:Journal Article Research Support, Non-U.S. Gov't Antimalarials Enzyme Inhibitors Ligands Protozoan Proteins Aspartic Acid Proteases EC 3.4.- Aspartic Acid Endopeptidases EC 3.4.23.- plus... plasmepsin II EC 3.4.23.39
Description
Résumé:2010 Wiley Periodicals, Inc.
The standard parameterization of the Linear Interaction Energy (LIE) method has been applied with quite good results to reproduce the experimental absolute binding free energies for several protein-ligand systems. However, we found that this parameterization failed to reproduce the experimental binding free energy of Plasmepsin II (PlmII) in complexes with inhibitors belonging to four dissimilar scaffolds. To overcome this fact, we developed three approaches of LIE, which combine systematic approaches to predict the inhibitor-specific values of α, β, and γ parameters, to gauge their ability to calculate the absolute binding free energies for these PlmII-Inhibitor complexes. Specifically: (i) we modified the linear relationship between the weighted nonpolar desolvation ratio (WNDR) and the α parameter, by introducing two models of the β parameter determined by the free energy perturbation (FEP) method in the absence of the constant term γ, and (ii) we developed a new parameterization model to investigate the linear correlation between WNDR and the correction term γ. Using these parameterizations, we were able to reproduce the experimental binding free energy from these systems with mean absolute errors lower than 1.5 kcal/mol
Description:Date Completed 21.12.2010
Date Revised 14.09.2010
published: Print
Citation Status MEDLINE
ISSN:1096-987X
DOI:10.1002/jcc.21566